3-hydroxybutyric acid has been researched along with Endometrial Neoplasms in 3 studies
3-Hydroxybutyric Acid: BUTYRIC ACID substituted in the beta or 3 position. It is one of the ketone bodies produced in the liver.
3-hydroxybutyric acid : A straight-chain 3-hydroxy monocarboxylic acid comprising a butyric acid core with a single hydroxy substituent in the 3- position; a ketone body whose levels are raised during ketosis, used as an energy source by the brain during fasting in humans. Also used to synthesise biodegradable plastics.
Endometrial Neoplasms: Tumors or cancer of ENDOMETRIUM, the mucous lining of the UTERUS. These neoplasms can be benign or malignant. Their classification and grading are based on the various cell types and the percent of undifferentiated cells.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In women with ovarian or endometrial cancer, a KD results in selective loss of fat mass and retention of lean mass." | 2.87 | A Ketogenic Diet Reduces Central Obesity and Serum Insulin in Women with Ovarian or Endometrial Cancer. ( Alvarez, RD; Arend, RC; Bevis, KS; Cohen, CW; Fontaine, KR; Gower, BA; Huh, WK; Kim, KH; Leath, CA; Straughn, JM, 2018) |
| "The serum metabolomics signature of endometrial cancer patients is peculiar because it differs from that of healthy controls and from that of benign endometrial disease and from other gynecological cancers (such as ovarian cancer)." | 1.48 | Metabolomic Signature of Endometrial Cancer. ( Di Cello, A; Guida, M; Landolfi, A; Martinelli, P; Sarno, L; Scala, G; Troisi, J; Venturella, R; Zullo, F, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Troisi, J | 1 |
| Sarno, L | 1 |
| Landolfi, A | 1 |
| Scala, G | 1 |
| Martinelli, P | 1 |
| Venturella, R | 1 |
| Di Cello, A | 1 |
| Zullo, F | 1 |
| Guida, M | 1 |
| Cohen, CW | 1 |
| Fontaine, KR | 1 |
| Arend, RC | 1 |
| Alvarez, RD | 1 |
| Leath, CA | 1 |
| Huh, WK | 1 |
| Bevis, KS | 1 |
| Kim, KH | 1 |
| Straughn, JM | 1 |
| Gower, BA | 1 |
| Bahado-Singh, RO | 1 |
| Lugade, A | 1 |
| Field, J | 1 |
| Al-Wahab, Z | 1 |
| Han, B | 1 |
| Mandal, R | 1 |
| Bjorndahl, TC | 1 |
| Turkoglu, O | 1 |
| Graham, SF | 1 |
| Wishart, D | 1 |
| Odunsi, K | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effects of a Combined Treatment With Myo-inositol, D-chiro-inositol and Glucomannan in Women With PCOS[NCT03608813] | 120 participants (Actual) | Observational | 2016-09-10 | Completed | |||
| Targeted Disruption to Cancer Metabolism Through Dietary Macronutrient Modification[NCT03171506] | 57 participants (Actual) | Interventional | 2015-11-09 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for 3-hydroxybutyric acid and Endometrial Neoplasms
| Article | Year |
|---|---|
A Ketogenic Diet Reduces Central Obesity and Serum Insulin in Women with Ovarian or Endometrial Cancer.
Topics: 3-Hydroxybutyric Acid; Body Composition; Body Fluid Compartments; Diet, Ketogenic; Endometrial Neopl | 2018 |
2 other studies available for 3-hydroxybutyric acid and Endometrial Neoplasms
| Article | Year |
|---|---|
Metabolomic Signature of Endometrial Cancer.
Topics: 3-Hydroxybutyric Acid; Aged; Biomarkers, Tumor; Case-Control Studies; Diagnosis, Differential; Endom | 2018 |
Metabolomic prediction of endometrial cancer.
Topics: 3-Hydroxybutyric Acid; Adult; Aged; Biological Assay; Biomarkers, Tumor; Case-Control Studies; Early | 2017 |